Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,13 USD | +1,80 % | -5,83 % | +28,41 % |
Resumen de negocios
Número de empleados: 12
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Shu-Chih Chen
FOU | Founder | 62 | 01/12/08 |
Steven Quay
CEO | Chief Executive Officer | 73 | 01/12/08 |
Heather Rees
DFI | Director of Finance/CFO | 51 | 01/01/17 |
Arezoo Mirad
CTO | Chief Tech/Sci/R&D Officer | - | 04/12 |
Richard Graydon
CTO | Chief Tech/Sci/R&D Officer | - | 25/10/22 |
Delly Behen
ADM | Chief Administrative Officer | - | 01/01/14 |
Eric van Zanten
IRC | Investor Relations Contact | - | 07/12/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 73 | 01/12/08 |
Director/Board Member | 66 | 01/03/14 | |
H. Remmel
BRD | Director/Board Member | 72 | 01/02/12 |
Shu-Chih Chen
FOU | Founder | 62 | 01/12/08 |
Stephen Galli
BRD | Director/Board Member | 77 | 01/07/11 |
Jonathan Finn
BRD | Director/Board Member | 50 | 08/11 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 127 077 462 | 125 684 004 ( 98,90 %) | 1 320 046 ( 1,039 %) | 98,90 % |
Acción B | 0 | 582 | 0 | 0 |
Información de la empresa
Atossa Therapeutics, Inc.
107 Spring Street
98104, Seattle
+206 588 0256
http://www.atossatherapeutics.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+28,41 % | 142 M | |
+34,14 % | 51,12 mil M | |
-6,54 % | 39,4 mil M | |
+34,92 % | 38,48 mil M | |
-12,11 % | 26,22 mil M | |
+12,62 % | 26,36 mil M | |
-13,43 % | 20,96 mil M | |
+43,73 % | 14,02 mil M | |
+31,81 % | 12,49 mil M | |
-4,54 % | 11,61 mil M |
- Bolsa de valores
- Acciones
- Acción ATOS
- Empresa Atossa Therapeutics, Inc.